🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

David Roman

Stock Analyst at Goldman Sachs

(3.33)
# 2,395
Out of 5,189 analysts
245
Total ratings
52.1%
Success rate
3.6%
Average return

Stocks Rated by David Roman

Edwards Lifesciences
Nov 5, 2026
Reiterated: Buy
Price Target: $98 → $115
Current: $101.85
Upside: +12.91%
Baxter International
Jul 15, 2026
Rated: Hold
Price Target: $17 → $21
Current: $25.39
Upside: -17.29%
Beta Bionics
Jul 15, 2026
Rated: Buy
Price Target: $17 → $19
Current: $13.36
Upside: +42.22%
Bausch + Lomb
Jul 14, 2026
Reiterated: Hold
Price Target: $19 → $21
Current: $19.38
Upside: +8.36%
Boston Scientific
Jul 14, 2026
Reiterated: Buy
Price Target: $71 → $57
Current: $41.98
Upside: +35.78%
Mobia Medical
Jul 14, 2026
Reiterated: Buy
Price Target: $31
Current: $11.85
Upside: +161.60%
Tandem Diabetes Care
Jul 14, 2026
Reiterated: Hold
Price Target: $21 → $16
Current: $17.46
Upside: -8.36%
Intuitive Surgical
Jun 15, 2026
Reiterated: Buy
Price Target: $558
Current: $399.05
Upside: +39.83%
Omada Health
Jun 10, 2026
Reiterated: Buy
Price Target: $26 → $25
Current: $11.87
Upside: +110.62%
Medtronic
Jun 4, 2026
Reiterated: Hold
Price Target: $84 → $83
Current: $99.94
Upside: -16.95%
Reiterated: Buy
Price Target: $14 → $24
Current: $16.01
Upside: +49.91%
Reiterated: Buy
Price Target: $121 → $113
Current: $103.00
Upside: +9.71%
Reiterated: Sell
Price Target: $89 → $88
Current: $94.75
Upside: -7.12%
Reiterated: Sell
Price Target: $73 → $61
Current: $58.88
Upside: +3.60%
Reiterated: Buy
Price Target: $237 → $205
Current: $133.17
Upside: +53.94%
Reiterated: Buy
Price Target: $7 → $8
Current: $7.45
Upside: +7.38%
Reiterated: Buy
Price Target: $153
Current: $237.31
Upside: -35.53%
Rated: Hold
Price Target: $28 → $24
Current: $28.73
Upside: -16.46%
Reiterated: Buy
Price Target: $80
Current: $79.32
Upside: +0.86%
Reiterated: Buy
Price Target: $20
Current: $20.15
Upside: -0.74%
Reiterated: Hold
Price Target: $73 → $72
Current: $90.73
Upside: -20.64%
Reiterated: Buy
Price Target: $54 → $50
Current: $37.04
Upside: +34.99%
Reiterated: Buy
Price Target: $17 → $16
Current: $17.42
Upside: -8.15%
Reiterated: Sell
Price Target: $54 → $66
Current: $84.50
Upside: -21.89%
Reiterated: Hold
Price Target: $357 → $361
Current: $310.00
Upside: +16.45%
Downgraded: Hold
Price Target: n/a
Current: $80.64
Upside: -
Reiterated: Hold
Price Target: $147
Current: $94.72
Upside: +55.19%
Initiated Coverage: Hold
Price Target: $192 → $167
Current: $212.78
Upside: -21.52%
Rated: Hold
Price Target: $24 → $17
Current: $25.10
Upside: -32.27%
Reiterated: Sell
Price Target: $93 → $88
Current: $101.10
Upside: -12.96%
Downgraded: Sell
Price Target: $18 → $21
Current: $66.89
Upside: n/a
Upgraded: Hold
Price Target: $39 → $29
Current: $120.16
Upside: n/a
Reiterated: Sell
Price Target: $103
Current: $106.38
Upside: n/a
Reiterated: Hold
Price Target: $44 → $15
Current: $6.08
Upside: n/a